Eryaspase: Completed Phase IIb enrollment

Erytech completed enrollment of 123 patients ages 65-85 who are newly diagnosed with AML and unfit for intensive chemotherapy in the open-label, European Phase IIb ENFORCE 1 trial comparing 100 IU/kg ...